1. Home
  2. AADI vs IROQ Comparison

AADI vs IROQ Comparison

Compare AADI & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AADI
  • IROQ
  • Stock Information
  • Founded
  • AADI 2011
  • IROQ 1883
  • Country
  • AADI United States
  • IROQ United States
  • Employees
  • AADI N/A
  • IROQ N/A
  • Industry
  • AADI Biotechnology: Pharmaceutical Preparations
  • IROQ Savings Institutions
  • Sector
  • AADI Health Care
  • IROQ Finance
  • Exchange
  • AADI Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • AADI 77.5M
  • IROQ 77.3M
  • IPO Year
  • AADI N/A
  • IROQ 2011
  • Fundamental
  • Price
  • AADI $2.79
  • IROQ $23.97
  • Analyst Decision
  • AADI Hold
  • IROQ
  • Analyst Count
  • AADI 3
  • IROQ 0
  • Target Price
  • AADI $1.75
  • IROQ N/A
  • AVG Volume (30 Days)
  • AADI 114.1K
  • IROQ 1.4K
  • Earning Date
  • AADI 03-12-2025
  • IROQ 01-30-2025
  • Dividend Yield
  • AADI N/A
  • IROQ 1.67%
  • EPS Growth
  • AADI N/A
  • IROQ 56.77
  • EPS
  • AADI N/A
  • IROQ 0.95
  • Revenue
  • AADI $25,070,000.00
  • IROQ $24,226,000.00
  • Revenue This Year
  • AADI $8.43
  • IROQ N/A
  • Revenue Next Year
  • AADI $5.41
  • IROQ N/A
  • P/E Ratio
  • AADI N/A
  • IROQ $25.25
  • Revenue Growth
  • AADI 7.80
  • IROQ 8.37
  • 52 Week Low
  • AADI $1.21
  • IROQ $14.85
  • 52 Week High
  • AADI $3.81
  • IROQ $25.00
  • Technical
  • Relative Strength Index (RSI)
  • AADI 48.57
  • IROQ 51.16
  • Support Level
  • AADI $2.56
  • IROQ $23.81
  • Resistance Level
  • AADI $2.94
  • IROQ $24.33
  • Average True Range (ATR)
  • AADI 0.13
  • IROQ 0.37
  • MACD
  • AADI 0.01
  • IROQ -0.02
  • Stochastic Oscillator
  • AADI 57.50
  • IROQ 40.46

About AADI Aadi Bioscience Inc.

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

Share on Social Networks: